Annette Nicke Selected Research

Annette Nicke Research Topics

Disease

8	Inflammation (Inflammations) 01/2023 - 01/2020
5	Neuroinflammatory Diseases 01/2023 - 01/2019
5	Status Epilepticus (Complex Partial Status Epilepticus) 01/2023 - 01/2020
4	Epilepsy (Aura) 01/2023 - 01/2020
3	Brain Diseases (Brain Disorder) 10/2022 - 01/2020
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2019
2	Seizures (Absence Seizure) 01/2023 - 01/2021
2	Tauopathies 01/2023 - 01/2022
2	Pathologic Processes 01/2020 - 01/2019
2	Schizophrenia (Dementia Praecox) 01/2020 - 12/2013
1	Paralysis (Palsy) 03/2024
1	Organophosphate Poisoning 03/2024
1	Alzheimer Disease (Alzheimer's Disease) 01/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023
1	Stroke (Strokes) 10/2022
1	Memory Disorders (Memory Loss) 01/2022
1	Encephalitis (Encephalitis, Rasmussen) 01/2022
1	Temporal Lobe Epilepsy 01/2021
1	Hearing Loss (Hearing Impairment) 01/2021
1	Cardiac Arrhythmias (Arrythmia) 01/2020
1	Neurobehavioral Manifestations 01/2020
1	Tobacco Use Disorder (Nicotine Dependence) 01/2017
1	Mood Disorders (Mood Disorder) 12/2013
1	Neuralgia (Stump Neuralgia) 12/2013
1	Hyperalgesia 12/2013
1	Pain (Aches) 09/2009

Drug/Important Bio-Agent (IBA)

15	Adenosine Triphosphate (ATP)IBA 01/2023 - 09/2009
14	Purinergic P2X7 ReceptorsIBA 01/2023 - 09/2009
4	Kainic Acid (Kainate)IBA 01/2023 - 01/2020
3	Purinergic Receptors (Receptors, Purine)IBA 10/2022 - 01/2020
2	Single-Domain AntibodiesIBA 10/2022 - 01/2022
2	CationsIBA 10/2022 - 12/2013
2	CytokinesIBA 01/2021 - 12/2013
1	OrganophosphatesIBA 03/2024
1	EsterasesIBA 03/2024
1	Acetylcholine (Acetylcholine Chloride)FDA Link 03/2024
1	4-(2-oxapentadeca-4-yne)phenylpropanoic acidIBA 03/2024
1	OximesIBA 03/2024
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 03/2024
1	RNA (Ribonucleic Acid)IBA 01/2023
1	JNJ-47965567IBA 01/2023
1	UbiquitinIBA 01/2023
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2023
1	Purinergic P2 Receptors (ADP Receptor)IBA 10/2022
1	salicylhydroxamic acid (SHAM)IBA 10/2022
1	LipopolysaccharidesIBA 01/2022
1	Ion Channels (Ion Channel)IBA 01/2022
1	Midazolam (Versed)FDA LinkGeneric 01/2022
1	Lorazepam (Ativan)FDA LinkGeneric 01/2022
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022
1	Phenytoin (Dilantin)FDA LinkGeneric 01/2022
1	Minocycline (Cyclops)FDA LinkGeneric 01/2022
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2022
1	ITH15004IBA 01/2022
1	Carbamazepine (Tegretol)FDA LinkGeneric 01/2022
1	tau Proteins (tau Protein)IBA 01/2022
1	ConvulsantsIBA 01/2022
1	NucleotidesIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	purineIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2020
1	Phencyclidine (Angel Dust)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2019
1	Conotoxins (Conotoxin)IBA 01/2017
1	Ligand-Gated Ion ChannelsIBA 01/2017

Therapy/Procedure

3	Intravenous Injections 01/2023 - 01/2022
3	Therapeutics 01/2022 - 01/2017
1	Drug Therapy (Chemotherapy) 01/2022